Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co‐morbidities | Zendy

Boriani Giuseppe | Zendy; Malavasi Vincenzo Livio | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co‐morbidities

Author(s) -

Boriani Giuseppe,

Malavasi Vincenzo Livio

Publication year - 2017

Publication title -

european journal of heart failure

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.149

H-Index - 133

eISSN - 1879-0844

pISSN - 1388-9842

DOI - 10.1002/ejhf.743

Subject(s) - medicine , implantable cardioverter defibrillator , heart failure , clinical trial , cardiac resynchronization therapy , myocardial infarction , sudden cardiac death , randomized controlled trial , canadian cardiovascular society , intensive care medicine , cardiology , ejection fraction , angina

This article refers to 'The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers,' by A.C. Ruwald et al., published in this issue on pages 377-386

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research